UnSurpass-CVOT

Quote





anonymous said:
Fake, it’s double blinded, how would they know…
Click to expand...
Well it may be a fake comment but the Surpass-CVOT DEFINITELY UNSURPASSED. I heard that it took nearly 4 years to begin to separate from Trulicity. The trial had to stop by year five failing to show non-inferiority. There were more CV deaths in the first 4 years with Mounjaro vs. Trulicity. I have a doc that told be she’s getting ready for a new wave of 1800-BAD-DRUG ads. She’s real worried about TikTok grabbing the negative news and scaring everyone.
 


anonymous said:
Well it may be a fake comment but the Surpass-CVOT DEFINITELY UNSURPASSED. I heard that it took nearly 4 years to begin to separate from Trulicity. The trial had to stop by year five failing to show non-inferiority. There were more CV deaths in the first 4 years with Mounjaro vs. Trulicity. I have a doc that told be she’s getting ready for a new wave of 1800-BAD-DRUG ads. She’s real worried about TikTok grabbing the negative news and scaring everyone.
Click to expand...
That’s super specific right there! I know the results will be not what was expected.
 






Dan Skovronsky saying
“I know it's frustrating for investors and for us perhaps to wait to longer time to get events. But of course, that's great news for patients when the event rates are slower, remembering that this is a head-to-head trial with a drug Trulicity that we already know is active in preventing events”

to analyst question below says it all. Lower expectation please.

“On SURPASS-CVOT, you mentioned it's slipped to 2025. I assume that implies the one interim look has come and gone. And then you're evaluating both noninferiority and superiority.

Would you agree that superiority is really what you need to show here and what's your confidence in achieving that?”
 






anonymous said:
I know who you are talking about
Why Ozempic is Better than Mounjaro: A Deeper Dive into Its Anti-Inflammatory Benefits, Cardiovascular Effects, and More
Click to expand...
LOL Wordpress Author-less article??? Nice Try East Coast NOVO rep. I don't need to read this to know that the SURPASS-CVOT trial is a bust. I saw it coming even in the Cardio Meta-Analysis showed Mounjaro only shows a CV benefit vs. Insulin. The sad Thing is Placebo shows a CV benefit vs. Insulin too. We have some trouble on the horizon with Mounjaro, do not worry folks we can sell a GLP-1 pill instead! It's like Dave Ricks knew this was coming and we go back to the proven science of a GLP-1! That is so bizarre! Who will be the first law firm to file a Class Action Lawsuit?
 


anonymous said:
LOL Wordpress Author-less article??? Nice Try East Coast NOVO rep. I don't need to read this to know that the SURPASS-CVOT trial is a bust. I saw it coming even in the Cardio Meta-Analysis showed Mounjaro only shows a CV benefit vs. Insulin. The sad Thing is Placebo shows a CV benefit vs. Insulin too. We have some trouble on the horizon with Mounjaro, do not worry folks we can sell a GLP-1 pill instead! It's like Dave Ricks knew this was coming and we go back to the proven science of a GLP-1! That is so bizarre! Who will be the first law firm to file a Class Action Lawsuit?
Click to expand...
Is the pill 100% glp-1? I know this doc too- his assistant helped him write it using chat gpt- he dictated.
 



Write your reply...
Top Bottom
Back
Quote